MaxCyte
(LSE) MXCT
MaxCyte Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$35.75M
Net Income (TTM)
$44.77M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
MXCT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MaxCyte
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
91
CEO
Maher Masoud
Website
www.maxcyte.comHeadquarters
Rockville, MD 20850, US
MXCT Financials
Key Financial Metrics (TTM)
Gross Margin
68%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
-24%
Return on Capital
-23%
Return on Assets
-22%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$31.53M
Operating Income
$51.20M
EBITDA
$46.41M
Operating Cash Flow
$27.61M
Capital Expenditure
$1.65M
Free Cash Flow
$29.26M
Cash & ST Invst.
$154.48M
Total Debt
$18.03M
MaxCyte Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.51M
-18.4%
Gross Profit
$6.99M
-21.8%
Gross Margin
82.14%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
114
N/A
Net Income
$12.36M
-31.8%
EBITDA
$12.93M
-18.8%
Quarterly Fundamentals
Net Cash
$108.06M
-22.2%
Accounts Receivable
$5.75M
+25.6%
Inventory
$7.93M
-28.9%
Long Term Debt
$17.20M
-2.6%
Short Term Debt
$1.31M
+49.0%
Return on Assets
-22.04%
N/A
Return on Invested Capital
-23.13%
N/A
Free Cash Flow
$10.44M
-103.5%
Operating Cash Flow
$9.85M
-103.8%